Table 5 Patient demographics for the matched cohort vs patients experiencing PASC related conditions

From: Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort

 

Case (COVID PCR (+)) with PASCa

Total case (COVID PCR (+))

Control (COVID PCR (-)) with PASCb

Total control (COVID PCR (-))

Total, n (%)

Total

4625 (100.0%)

28,118 (100.0%)

9745 (100.0%)

70,293 (100.0%)

Sex, n (%)

Female

2866 (62.0%)

15,993 (56.9%)

6092 (62.5%)

40,396 (57.5%)

Male

1759 (38.0%)

12,125 (43.1%)

3653 (37.5%)

29,897 (42.5%)

Age in years, n (%)

18–29

866 (18.7%)

5791 (20.6%)

1985 (20.4%)

14,805 (21.1%)

30–39

899 (19.4%)

5624 (20.0%)

1898 (19.5%)

14,028 (20.0%)

40–49

810 (17.5%)

5352 (19.0%)

1695 (17.4%)

12,828 (18.2%)

50–64

1355 (29.3%)

7948 (28.3%)

2693 (27.6%)

19,543 (27.8%)

65–74

480 (10.4%)

2449 (8.7%)

1018 (10.4%)

6516 (9.3%)

75–84

178 (3.8%)

775 (2.8%)

363 (3.7%)

2109 (3.0%)

85+

37 (0.8%)

179 (0.6%)

93 (1.0%)

464 (0.7%)

Race/Ethnicity (self-reported), n (%)

Asian

465 (10.1%)

3018 (10.7%)

977 (10.0%)

7772 (11.1%)

Black

1903 (41.1%)

11,402 (40.6%)

4266 (43.8%)

29,680 (42.2%)

Hispanic

1189 (25.7%)

6877 (24.5%)

2012 (20.6%)

14,057 (20.0%)

White

877 (19.0%)

5325 (18.9%)

2041 (20.9%)

14,963 (21.3%)

Unknown

191 (4.1%)

1496 (5.3%)

449 (4.6%)

3821 (5.4%)

Service area, n (%)

Baltimore

907 (19.6%)

5199 (18.5%)

1987 (20.4%)

13,177 (18.7%)

DC and Southern Maryland

2127 (46.0%)

13,337 (47.4%)

4536 (46.5%)

33,247 (47.3%)

Northern Virginia

1590 (34.4%)

9578 (34.1%)

3222 (33.1%)

23,861 (33.9%)

Unknown

1 (0.0%)

4 (0.0%)

0 (0.0%)

8 (0.0%)

BMI, n (%)

<18.5 (Underweight)

22 (0.5%)

146 (0.5%)

85 (0.9%)

597 (0.8%)

18.5–24.9 (Healthy Weight)

601 (13.0%)

3750 (13.3%)

1639 (16.8%)

12,179 (17.3%)

25–29.9 (Overweight)

1043 (22.6%)

6454 (23.0%)

2331 (23.9%)

16,680 (23.7%)

30–39.9 (Obesity)

1418 (30.7%)

7956 (28.3%)

2624 (26.9%)

17,916 (25.5%)

40 + (Severe Obesity)

468 (10.1%)

2325 (8.3%)

802 (8.2%)

4781 (6.8%)

No Result

1073 (23.2%)

7487 (26.6%)

2264 (23.2%)

18,140 (25.8%)

Co-morbidities, n (%)

Chronic Kidney Disease

179 (3.9%)

849 (3.0%)

402 (4.1%)

2285 (3.3%)

COPD

45 (1.0%)

266 (0.9%)

182 (1.9%)

935 (1.3%)

Diabetes Mellitus

981 (21.2%)

5271 (18.7%)

1756 (18.0%)

11,498 (16.4%)

Hepatitis B

31 (0.7%)

200 (0.7%)

75 (0.8%)

532 (0.8%)

HIV

50 (1.1%)

239 (0.8%)

92 (0.9%)

567 (0.8%)

Pregnancy

126 (2.7%)

489 (1.7%)

310 (3.2%)

1486 (2.1%)

Malignancy

140 (3.0%)

729 (2.6%)

485 (5.0%)

2598 (3.7%)

Hospitalizationc, n (%)

Hospitalization

239 (5.2%)

511 (1.8%)

665 (6.8%)

1366 (1.9%)

Death Post Indexd, n (%)

Death

8 (0.2%)

42 (0.1%)

30 (0.3%)

58 (0.1%)

  1. aCOVID PCR( + ) patients that experienced at least one PASC related condition in the acute and persistent and/or late periods. bCOVID PCR(-) patients that experienced at least one PASC related condition in the acute and persistent and/or late periods. cHospitalization represents if a patient was hospitalized in the 30–120-time period post index date. dDeath represents if a patient died in the 0-120 days post index.
Back to article page